SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001279569-08-001349
Filing Date
2008-11-26
Accepted
2008-11-26 16:15:28
Documents
7
Period of Report
2008-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F lorus20f.htm 20-F 3097279
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex121.htm EX-12.1 16315
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex122.htm EX-12.2 16221
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES ex131.htm EX-13.1 6253
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES ex132.htm EX-13.2 6568
6 CHART clinical_development.jpg GRAPHIC 135583
7 LOGO kpmg.jpg GRAPHIC 5144
  Complete submission text file 0001279569-08-001349.txt   3338456
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-32001 | Film No.: 081218166
SIC: 2836 Biological Products, (No Diagnostic Substances)